Shopping Cart 0
Cart Subtotal
USD 0

Smart Insulin Pens Market: Current Analysis and Forecast (2021-2027)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 3500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4900

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 6860

Details

Smart insulin pens are used for external insulin delivery thus offering an easy to carry solution to diabetes management. The demand for the insulin pens has increased considerably in the recent years owing to the increase in incidence of diabetic patients coupled with their cost-effective nature as compared to insulin pumps.

Smart insulin pens offer several benefits as compared to other insulin delivery devices such as it is easier to use than syringe and being portable in nature, can be easily used outside home. In addition, the pen allows to dial the dose accurately, which helps the people with vision problems to administer insulin easily. Increasing prevalence of diabetes among the population, rising government initiatives and widening margins of healthcare spending are some of the factors significantly impacting the demand of smart diabetes management solutions. However, stringent government regulatory policies and long, tedious approval procedure, lack of healthcare infrastructure and unavailability of resources to support R&D work in poor countries has been restricting the growth of smart insulin pens market.

Based on types, the market is fragmented into first generation and second-generation devices. The second-generation segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to its easy portability and wireless connectivity.

Based on the end-users, the market is fragmented into hospitals, ambulatory surgery centers, and home care settings. The homecare settings segment on account of increasing geriatric population and rise self-administration among patients has generated revenue of USD XX million in 2020 and is anticipated to reach USD XX million by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027).

Based on the distribution channel, the market is fragmented into hospital pharmacy, online sales, retail pharmacy, and diabetes clinics/centres. The retail pharmacy segment generated revenue of USD XX million in 2020 and is anticipated to reach USD XX million by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027).

For a better understanding of the market adoption of the Single Pair Ethernet market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the Smart Insulin Pens industry and generated revenue of USD XX million in 2020 owing to the high prevalence for diabetes. The North American and Caribbean region spent some 325 billion U.S. dollars on health care for people with diabetes in 2019. However, the Asia Pacific region would grow at the highest CAGR during the forecast period due to its high population base and increase in incidence of diabetic patients.

Some of the major players operating in the market include Eli Lilly and Company, Novo Nordisk, Companion Medical, DIAMESCO, Emperra GmbH, Companion Medical, Ypsomed holding AG, F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co., Medtronics, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions
READ MORE

Table Of Content

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Smart Insulin Pens Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Smart Insulin Pens Market

2.1.1 Main Objective of the Global Smart Insulin Pens Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER SMART INSULIN PENS INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL SMART INSULIN PENS MARKET REVENUE

8 MARKET INSIGHTS BY TYPE

8.1 First Generation

8.2 Second Generation

9 MARKET INSIGHTS BY USABILITY

9.1 Pre-Filled

9.2 Reusable

10 MARKET INSIGHTS BY END-USER

10.1 Hospitals

10.2 Ambulatory Surgery Centers

10.3 Homecare Settings

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA SMART INSULIN PENS MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE SMART INSULIN PENS MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC SMART INSULIN PENS MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 South Korea

11.3.6 Rest of Asia Pacific

11.4 REST OF THE WORLD SMART INSULIN PENS MARKET

12 SMART INSULIN PENS MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 SMART INSULIN PENS MARKET OPPORTUNITIES

17 SMART INSULIN PENS MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Medtronics

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1 Revenue Split

19.1.6.2 Financial Overview of Medtronics

19.1.7 Recent Developments

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 Eli Lilly and Company

19.3 Novo Nordisk

19.4 Companion Medical, DIAMESCO

19.5 Emperra GmbH

19.6 Companion Medical

19.7 Ypsomed holding AG

19.8 F. Hoffmann-La Roche AG

19.9 Insulet Corporation

19.10 Snuza International

20 DISCLAIMER

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Eli Lilly and Company, Novo Nordisk, DIAMESCO, Emperra GmbH, Ypsomed holding AG, F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co., and Medtronics

Company Profile

Company Profile Title

Smart insulin pens are used for external insulin delivery thus offering an easy to carry solution to diabetes management. The demand for the insulin pens has increased considerably in the recent years owing to the increase in incidence of diabetic patients coupled with their cost-effective nature as compared to insulin pumps.

Smart insulin pens offer several benefits as compared to other insulin delivery devices such as it is easier to use than syringe and being portable in nature, can be easily used outside home. In addition, the pen allows to dial the dose accurately, which helps the people with vision problems to administer insulin easily. Increasing prevalence of diabetes among the population, rising government initiatives and widening margins of healthcare spending are some of the factors significantly impacting the demand of smart diabetes management solutions. However, stringent government regulatory policies and long, tedious approval procedure, lack of healthcare infrastructure and unavailability of resources to support R&D work in poor countries has been restricting the growth of smart insulin pens market.

Based on types, the market is fragmented into first generation and second-generation devices. The second-generation segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to its easy portability and wireless connectivity.

Based on the end-users, the market is fragmented into hospitals, ambulatory surgery centers, and home care settings. The homecare settings segment on account of increasing geriatric population and rise self-administration among patients has generated revenue of USD XX million in 2020 and is anticipated to reach USD XX million by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027).

Based on the distribution channel, the market is fragmented into hospital pharmacy, online sales, retail pharmacy, and diabetes clinics/centres. The retail pharmacy segment generated revenue of USD XX million in 2020 and is anticipated to reach USD XX million by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027).

For a better understanding of the market adoption of the Single Pair Ethernet market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the Smart Insulin Pens industry and generated revenue of USD XX million in 2020 owing to the high prevalence for diabetes. The North American and Caribbean region spent some 325 billion U.S. dollars on health care for people with diabetes in 2019. However, the Asia Pacific region would grow at the highest CAGR during the forecast period due to its high population base and increase in incidence of diabetic patients.

Some of the major players operating in the market include Eli Lilly and Company, Novo Nordisk, Companion Medical, DIAMESCO, Emperra GmbH, Companion Medical, Ypsomed holding AG, F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co., Medtronics, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions
READ MORE

Scope

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Smart Insulin Pens Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Smart Insulin Pens Market

2.1.1 Main Objective of the Global Smart Insulin Pens Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER SMART INSULIN PENS INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL SMART INSULIN PENS MARKET REVENUE

8 MARKET INSIGHTS BY TYPE

8.1 First Generation

8.2 Second Generation

9 MARKET INSIGHTS BY USABILITY

9.1 Pre-Filled

9.2 Reusable

10 MARKET INSIGHTS BY END-USER

10.1 Hospitals

10.2 Ambulatory Surgery Centers

10.3 Homecare Settings

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA SMART INSULIN PENS MARKET

11.1.1 United States

11.1.2 Canada

11.1.3 Rest of North America

11.2 EUROPE SMART INSULIN PENS MARKET

11.2.1 Germany

11.2.2 France

11.2.3 United Kingdom

11.2.4 Spain

11.2.5 Italy

11.2.6 Rest of Europe

11.3 ASIA PACIFIC SMART INSULIN PENS MARKET

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 South Korea

11.3.6 Rest of Asia Pacific

11.4 REST OF THE WORLD SMART INSULIN PENS MARKET

12 SMART INSULIN PENS MARKET DYNAMICS

12.1 Market Drivers

12.2 Market Challenges

12.3 Impact Analysis

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

14.1 Demand Side Analysis

14.2 Supply Side Analysis

14.2.1 Top Product Launches

14.2.2 Top Business Partnerships

14.2.3 Top Merger & Acquisitions

15 VALUE CHAIN ANALYSIS

16 SMART INSULIN PENS MARKET OPPORTUNITIES

17 SMART INSULIN PENS MARKET TRENDS & INSIGHTS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis

18.1.1 Bargaining power of Supplier

18.1.2 Bargaining power of Buyer

18.1.3 Industry Rivalry

18.1.4 Availability of Substitute

18.1.5 Threat of new Entrants

19 COMPANY PROFILED

19.1 Medtronics

19.1.1 Key Facts

19.1.2 Business Description

19.1.3 Key Product/Services Offerings

19.1.4 Growth Strategy

19.1.5 SWOT Analysis

19.1.6 Key Financials

19.1.6.1 Revenue Split

19.1.6.2 Financial Overview of Medtronics

19.1.7 Recent Developments

19.1.7.1 Product Launch

19.1.7.2 Partnerships

19.1.7.3 Business Expansion and Investments

19.1.7.4 Merger and Acquisition

19.2 Eli Lilly and Company

19.3 Novo Nordisk

19.4 Companion Medical, DIAMESCO

19.5 Emperra GmbH

19.6 Companion Medical

19.7 Ypsomed holding AG

19.8 F. Hoffmann-La Roche AG

19.9 Insulet Corporation

19.10 Snuza International

20 DISCLAIMER

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Eli Lilly and Company, Novo Nordisk, DIAMESCO, Emperra GmbH, Ypsomed holding AG, F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co., and Medtronics